The Korean Society of Cardiometabolic Syndrome (KSCMS), which spun off from the Korean Society of Cardiology as of Jan. 1, held its first official event, “2nd Asia-Pacific CardioMetabolic Syndrome CONGRESS” (APCMS 2019) at a hotel in Seoul, Friday.
During the international forum, the society announced its plans to become international at a news conference.
|Koh Kwang-kon, president of the Korean Society of Cardiometabolic Syndrome, speaks during a news conference at the “2nd Asia-Pacific CardioMetabolic Syndrome CONGRESS” at a hotel in Seoul, Friday.|
KSCMS President Koh Kwang-kon said the society first started as a research organ under the cardiology society in 2014 to improve the prognosis and reduce the mortality rate of patients with the cardiometabolic syndrome. However, the group needed expansion into the KSCMS for broader discussions with researchers around the world including Europe and the U.S., beyond the Asia-Pacific region, he said.
“KSCMS is the only society in cardiometabolic syndrome in the world. To emphasize its international role, we excluded ‘Korea’ from the society’s name,” Koh said.
In the next year’s event of APCMS 2020, Jean-Pierre Després of Laval University from Canada, the winner of Scientific Achievement Award, will participate as a plenary lecturer, he added.
“We also plan to publish an international journal by 2021 to solidify our standing as an official society,” Koh said.
If the journal is published as scheduled, it will be the world’s first journal in cardiometabolic syndrome, he emphasized.
<© Korea Biomedical Review, All rights reserved.>